SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,837,074 | -24.6% | 1,105,785 | +1.1% | 0.00% | – |
Q2 2023 | $5,087,663 | -62.3% | 1,094,121 | -62.6% | 0.00% | -100.0% |
Q1 2023 | $13,502,929 | -54.9% | 2,922,712 | -21.1% | 0.00% | 0.0% |
Q4 2022 | $29,916,766 | +551.1% | 3,702,570 | +347.2% | 0.00% | – |
Q3 2022 | $4,595,000 | +9.7% | 827,885 | +3.0% | 0.00% | – |
Q2 2022 | $4,187,000 | -80.7% | 803,585 | -69.6% | 0.00% | -100.0% |
Q1 2022 | $21,721,000 | -8.2% | 2,642,486 | +66.1% | 0.00% | 0.0% |
Q4 2021 | $23,672,000 | -26.4% | 1,590,837 | -6.6% | 0.00% | -50.0% |
Q3 2021 | $32,157,000 | -22.6% | 1,702,350 | -23.8% | 0.00% | 0.0% |
Q2 2021 | $41,524,000 | -27.4% | 2,233,692 | -11.2% | 0.00% | -33.3% |
Q1 2021 | $57,222,000 | +482.1% | 2,514,164 | +455.3% | 0.00% | +200.0% |
Q4 2020 | $9,830,000 | +201.9% | 452,770 | +39.7% | 0.00% | – |
Q3 2020 | $3,256,000 | +102.6% | 324,003 | +56.4% | 0.00% | – |
Q2 2020 | $1,607,000 | -11.8% | 207,107 | +16.0% | 0.00% | – |
Q1 2020 | $1,822,000 | -2.3% | 178,605 | +5.4% | 0.00% | – |
Q4 2019 | $1,864,000 | +31.5% | 169,466 | +8.7% | 0.00% | – |
Q3 2019 | $1,417,000 | -16.3% | 155,838 | +4.8% | 0.00% | – |
Q2 2019 | $1,692,000 | +70.1% | 148,659 | +70.1% | 0.00% | – |
Q1 2019 | $995,000 | +373.8% | 87,374 | +275.2% | 0.00% | – |
Q4 2018 | $210,000 | – | 23,287 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |